OUTCOMES OF EARLY-STAGE BREAST CANCER SURGERY IN ELDERLY PATIENTS AT THONG NHAT HOSPITAL
Main Article Content
Abstract
Background: Breast cancer has emerged as a major health and social burden in the context of population aging. Older patients often present with multiple comorbidities, leading to more complex treatments. Domestic data on breast cancer surgery in the elderly remain limited. Methods: A cross-sectional descriptive study was conducted in 57 women aged ≥60 years with stage I–II breast cancer (cT1–2, cN0–1, cM0) who underwent surgery at Thong Nhat Hospital 08/2021 – 08/2025. Results: The mean age was 69.8 ± 7.4 years, mean BMI 23.3 ± 3.0 kg/m², and median Charlson Comorbidity Index (CCI) was 3. The main presenting symptom was a palpable mass (91.2%). Histology showed invasive ductal carcinoma in 73.7% and invasive lobular carcinoma in 15.8%. ER/PR positivity was observed in more than 65%. Mastectomy accounted for 94.7%, sentinel lymph node biopsy 59.6%, and axillary lymph node dissection 40.4%. Early complications occurred in 12.3% (infection, delayed wound healing), and late complications included lymphedema (14.0%) and chronic pain (7.0%). Major complications were 7.0%, with no 30-day mortality. These findings are consistent with international data, indicating that surgery is safe and provides effective disease control in elderly patients. Conclusion: Surgery for early-stage breast cancer in patients aged ≥60 years is safe, with low complication rates and favorable OS and DFS. Individualized surgical decision-making (particularly regarding axillary management) and integration of geriatric assessment are essential to optimize treatment and quality of life.
Article Details
Keywords
breast cancer, elderly, overall survival, disease-free survival
References
2. Zaheed M, Barta SK, Bao T. Breast cancer in older women: current landscape and future directions. J Geriatr Oncol. 2022;13(5):619-27.
3. Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Chronic comorbidity and age are both independent risk factors for breast cancer survival: A population-based cohort study. J Geriatr Oncol. 2021;12(4):646-53.
4. DeBoniface J, Szulkin R, Johansson ALV. Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women. Br J Surg. 2023;110(3):344–352. doi:10.1093/bjs/znac411.
5. Giuliano AE, et al. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018;25(7):1783-1785.
6. Loibl S, Poortmans P, et al. Early breast cancer: ESMO Clinical Practice Guideline. Ann Oncol. 2024.
7. Lim YX, et al. Breast cancer in Asia: incidence, mortality, early detection, mammography programs and risk-based screening initiatives. Cancers (Basel). 2022;14(17):4213.
8. Gentilini O, Veronesi U, Pagan E, et al. Sentinel-node biopsy or axillary dissection in breast cancer (SOUND): a randomized, multicentre, non-inferiority trial. Lancet Oncol. 2023;24(12):1261-1272. doi:10.1016/S1470-2045(23)00444-2.
9. Reimer T, Stachs A, Nekljudova V, et al. Randomized trial evaluating omission of axillary surgery in breast cancer with sentinel-node-negative or sentinel-node-positive disease: INSEMA trial. N Engl J Med. 2024;390(8):716-728. doi:10.1056/NEJMoa2312979.
10. Kalinsky K, Barlow WE, Meric-Bernstam F, et al. 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336-2347. doi:10.1056/NEJMoa2108873.